Related Experiment Video
Updated: Jun 8, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease
Yoshihiro Noda1, Sho-ichi Yamagishi, Takanori Matsui
1Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume, Japan.
Insights
Increased p66(shc) gene expression in peripheral blood monocytes (PBMs) is linked to coronary artery disease (CAD) in Japanese individuals. This finding suggests p66(shc) may serve as a novel biomarker for detecting CAD.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genetics
Background:
- The p66(shc) protein regulates cellular responses to oxidative stress and is implicated in atherosclerosis in animal models.
- The association between p66(shc) gene expression and human coronary artery disease (CAD) has not been previously established.
Purpose of the Study:
- To investigate whether p66(shc) gene expression is elevated in peripheral blood monocytes (PBMs) of patients with CAD compared to controls.
- To determine if p66(shc) gene expression is an independent predictor of CAD.
Main Methods:
- Quantitative real-time reverse transcription-polymerase chain reaction was used to measure p66(shc) gene expression levels in PBMs.
- Uni- and multivariate analyses were performed to identify correlates of CAD in 40 Japanese subjects undergoing coronary angiography.
- CAD was defined by >75% obstruction in a major coronary artery or prior percutaneous coronary intervention.
Main Results:
- p66(shc) gene expression levels in PBMs were significantly higher in patients with CAD than in non-CAD subjects.
- Multiple regression analysis indicated that p66(shc) gene expression and hypertension medication were independent predictors of CAD.
- p66(shc) expression levels increased proportionally with the number of diseased coronary vessels.
Conclusions:
- This study provides the first evidence that elevated p66(shc) gene expression in PBMs is independently associated with CAD in Japanese individuals.
- p66(shc) gene expression in PBMs may represent a novel biomarker for the diagnosis of CAD in humans.
Background:
The p66(shc) protein has been shown to control cellular responses to oxidative stress, being involved in atherosclerosis in animal models. However, the relationship between the p66(shc) gene expression levels and coronary artery disease (CAD) in humans remains unknown. In this study, we examined whether the p66(shc) gene expression in peripheral blood monocytes (PBMs) was increased in patients with CAD, compared with age- and sex-matched subjects without CAD.
Hypothesis:
We hypothesize that the p66(shc) gene expression level in PBMs is increased in patients with CAD.
Methods:
Forty consecutive Japanese subjects who underwent coronary angiography for suspected CAD were enrolled in this study. The p66(shc) gene expression levels in PBMs were quantitatively measured by real-time reverse transcription-polymerase chain reactions. Uni- and multivariate analyses were applied for the correlates of CAD. CAD was diagnosed if there was > 75% obstruction of at least 1 major coronary artery or a history of percutaneous coronary intervention.
Results:
There were no significant differences of blood chemistries and clinical characteristics between the patients with and without CAD, except the number of subjects who were on hypertension medication. The p66(shc) gene expression levels in PBMs were significantly higher in CAD patients compared with non-CAD subjects. Multiple stepwise regression analysis revealed that the p66(shc) gene expression levels and hypertension medication were independently related to CAD (R(2)=0.287). Further, the p66(shc) gene expres- sion levels were significantly increased (P < 0.05) in proportion to the number of diseased vessels.
Conclusions:
The present study is the first demonstration that increased the p66(shc) gene expression in PBMs is independently associated with CAD in Japanese subjects. The p66(shc) gene expression level in PBMs may be a novel biomarker of CAD in humans.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome III: Diagnostic Studies